Due to the role of IL-27 in the regulation T cell-mediated inflammation (Tait Wojno et al., 2019), inhibition of IL-27 is currently being explored for its use in the inhibition of aberrant IL-27 signaling in cancer (Patnaik et al., 2021). This evidence concerns the gene IL27 and cancer.